Connexa Sports (YYAI) 10-Q 22 Mar 21 2021 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Jan. 31, 2021	Mar. 22, 2021
Cover [Abstract]
Entity Registrant Name	Slinger Bag Inc.
Entity Central Index Key	0001674440
Document Type	10-Q
Document Period End Date	Jan. 31, 2021
Amendment Flag	false
Current Fiscal Year End Date	--04-30
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		27,346,746
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jan. 31, 2021	Apr. 30, 2020
Current assets
Cash	$ 330,441	$ 79,847
Accounts receivable	1,433,312
Inventory	2,321,426	919,644
Prepaid expenses and other current assets	339,161	381,510
Total current assets	4,424,340	1,381,001
Intangible assets, net	114,284
Total assets	4,538,624	1,381,001
Current liabilities
Accounts payable and accrued expenses	2,315,614	971,612
Deferred revenue	113,292	179,366
Accrued interest	19,500	17,500
Accrued interest - related parties	592,997	138,967
Notes payable - related party	6,065,890	2,100,000
Notes payable, net	1,000,000
Convertible note payable , net		82,128
Derivative liability		620,238
Due to related parties	1,085,434	377,106
Total current liabilities	11,192,727	4,486,917
Long-term liabilities
Long-term portion of convertible notes payable , net		1,493,939
Note payable, net		393,975
Total liabilities	11,192,727	6,374,831
Commitments and contingencies
Stockholders' deficit
Common stock, $0.001 par value, 300,000,000 shares authorized, 27,346,746 and 24,749,354 shares issued and outstanding as of January 31,2021 (unaudited) and April 30, 2020, respectively; 6,921,299 shares issuable as of January 31, 2021 (unaudited)	27,347	24,749
Additional paid-in capital	8,743,458	5,214,970
Accumulated other comprehensive loss	(7,157)	(5,036)
Accumulated deficit	(15,417,751)	(10,228,513)
Total stockholders' deficit	(6,654,103)	(4,993,830)
Total liabilities and stockholders' deficit	$ 4,538,624	$ 1,381,001

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jan. 31, 2021	Dec. 03, 2020	Apr. 30, 2020	Feb. 25, 2020	Feb. 24, 2020
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001		$ 0.001
Common stock, shares authorized	300,000,000		300,000,000	300,000,000	75,000,000
Common stock, shares issued	27,346,746		24,749,354
Common stock, shares outstanding	27,346,746		24,749,354
Shares issuable	6,921,299	6,921,299	6,921,299

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jan. 31, 2021	Jan. 31, 2020	Jan. 31, 2021	Jan. 31, 2020
Income Statement [Abstract]
Net sales	$ 4,123,648		$ 7,308,701
Cost of sales	3,245,493		5,762,143
Gross profit	878,155		1,546,558
Operating expenses:
Selling and marketing expenses	351,845	96,870	1,051,785	229,610
General and administrative expenses	1,121,993	512,051	2,526,926	1,187,650
Stock-based compensation	263,633		447,478
Research and development costs	137,156	19,530	180,705	153,099
Total operating expenses	1,874,627	628,451	4,206,894	1,570,359
Loss from operations	(996,472)	(628,451)	(2,660,336)	(1,570,359)
Other expenses (income):
Amortization of debt discount	39,175	602,963	325,426	924,933
Change in value of derivatives			(566,667)
Loss on extinguishment of debt	95,760		2,095,247
Induced conversion loss			51,412
Interest expense - related party	137,480	7,500	454,029	12,500
Interest expense	22,199	107,190	169,455	553,545
Total other expense (income)	294,614	717,653	2,528,902	1,490,978
Loss before income taxes	(1,291,086)	(1,346,104)	(5,189,238)	(3,061,337)
Provision for (benefit from) income taxes
Net loss	(1,291,086)	(1,346,104)	(5,189,238)	(3,061,337)
Other comprehensive loss, net of tax
Foreign currency translation adjustments	816	1,559	(2,121)	(4,451)
Total other comprehensive loss, net of tax	816	1,559	(2,121)	(4,451)
Comprehensive loss	$ (1,290,270)	$ (1,344,545)	$ (5,191,359)	$ (3,065,788)
Net loss per share, basic and diluted	$ (0.05)	$ (0.06)	$ (0.20)	$ (0.13)
Weighted average number of common shares outstanding, basic and diluted	26,795,030	24,380,000	26,497,184	24,380,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income [Member]	Accumulated Deficit [Member]	Total
Balance at Apr. 30, 2019	$ 24,380	$ 2,520		$ (33,091)	$ (6,191)
Balance, shares at Apr. 30, 2019	24,380,000
Contribution of Slinger Bag Limited			(2)	(967,678)	(967,680)
Foreign currency translation			(17)		(17)
Net loss				(265,067)	(265,067)
Balance at Jul. 31, 2019	$ 24,380	2,520	(19)	(1,265,836)	(1,238,955)
Balance, shares at Jul. 31, 2019	24,380,000
Balance at Apr. 30, 2019	$ 24,380	2,520		(33,091)	(6,191)
Balance, shares at Apr. 30, 2019	24,380,000
Net loss					(3,061,337)
Balance at Jan. 31, 2020	$ 24,380	1,177,758	(4,453)	(4,062,106)	(2,864,421)
Balance, shares at Jan. 31, 2020	24,380,000
Balance at Jul. 31, 2019	$ 24,380	2,520	(19)	(1,265,836)	(1,238,955)
Balance, shares at Jul. 31, 2019	24,380,000
Foreign currency translation			(5,993)		(5,993)
Shares issued related to note payable		1,492,188			1,492,188
Shares issued related to note payable, shares
Distribution to shareholder		(332,239)			(332,239)
Forgiveness of net liabilities owed to former majority shareholder		15,289			15,289
Net loss				(1,450,166)	(1,450,166)
Balance at Oct. 31, 2019	$ 24,380	1,177,758	(6,012)	(2,716,002)	(1,519,876)
Balance, shares at Oct. 31, 2019	24,380,000
Foreign currency translation			1,559		1,559
Net loss				(1,346,104)	(1,346,104)
Balance at Jan. 31, 2020	$ 24,380	1,177,758	(4,453)	(4,062,106)	(2,864,421)
Balance, shares at Jan. 31, 2020	24,380,000
Balance at Apr. 30, 2020	$ 24,749	5,214,970	(5,036)	(10,228,513)	(4,993,830)
Balance, shares at Apr. 30, 2020	24,749,354
Foreign currency translation			(1,393)		(1,393)
Shares issued related to note payable	$ 1,217	(1,217)
Shares issued related to note payable, shares	1,216,560
Shares issued for services	$ 244	65,582			65,826
Shares issued for services, shares	243,800
Net loss				(1,374,026)	(1,374,026)
Balance at Jul. 31, 2020	$ 26,210	5,279,335	(6,429)	(11,602,539)	(6,303,423)
Balance, shares at Jul. 31, 2020	26,209,714
Balance at Apr. 30, 2020	$ 24,749	5,214,970	(5,036)	(10,228,513)	(4,993,830)
Balance, shares at Apr. 30, 2020	24,749,354
Net loss					(5,189,238)
Balance at Jan. 31, 2021	$ 27,347	8,743,458	(7,157)	(15,417,751)	(6,654,103)
Balance, shares at Jan. 31, 2021	27,346,746
Balance at Jul. 31, 2020	$ 26,210	5,279,335	(6,429)	(11,602,539)	(6,303,423)
Balance, shares at Jul. 31, 2020	26,209,714
Foreign currency translation			(1,544)		(1,544)
Shares issued for services	$ 100	113,900			114,000
Shares issued for services, shares	100,000
Shares issued for conversion of convertible debt	$ 300	238,149			238,449
Shares issued for conversion of convertible debt, shares	300,000
Warrants issued with note payable		2,069,617			2,069,617
Stock-based compensation		4,019			4,019
Net loss				(2,524,126)	(2,524,126)
Balance at Oct. 31, 2020	$ 26,610	7,705,020	(7,973)	(14,126,665)	(6,403,008)
Balance, shares at Oct. 31, 2020	26,609,714
Foreign currency translation			816		816
Warrants issued with note payable		124,931			124,931
Stock-based compensation		130,275			130,275
Shares issued in connection with services	$ 202	198,184			198,386
Shares issued in connection with services, shares	202,032
Shares issued in connection with purchase of trademark	$ 35	35,316			35,351
Shares issued in connection with purchase of trademark, shares	35,000
Shares issued in connection with conversion of debt	$ 500	499,500			500,000
Shares issued in connection with conversion of debt, shares	500,000
Warrants issued in connection with purchase of trademark		50,232			50,232
Net loss				(1,291,086)	(1,291,086)
Balance at Jan. 31, 2021	$ 27,347	$ 8,743,458	$ (7,157)	$ (15,417,751)	$ (6,654,103)
Balance, shares at Jan. 31, 2021	27,346,746

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Jan. 31, 2021	Jan. 31, 2020
Cash flows from operating activities
Net loss	$ (5,189,238)	$ (3,061,337)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,299	650
Change in value of derivatives	(566,667)
Stock-based compensation	447,478
Loss on extinguishment of debt	2,095,247
Induced conversion loss	51,412
Non-cash interest expense		358,855
Amortization of debt discount	325,426	924,933
Changes in operating assets and liabilities:
Accounts receivable	(1,433,312)
Inventory	(1,401,782)	(374,376)
Prepaid expenses and other current assets	82,099	(1,823,922)
Accounts payable and accrued expenses	1,352,468	549,425
Deferred revenue	(66,074)	(26,570)
Accrued interest – related parties	454,030	31,323
Due to related parties	708,328	(11,319)
Net cash used in operating activities	(3,139,286)	(3,432,339)
Cash flows from investing activities
Proceeds from contribution of net assets of SBL		73,400
Purchase of trademark	(30,000)
Net cash provided by investing activities	(30,000)	73,400
Cash flows from financing activities
Distribution to shareholder		(332,239)
Proceeds from notes payable - related party	2,300,000	1,900,000
Proceeds from note payable	1,120,000	1,700,000
Proceeds from convertible note payable		125,000
Net cash provided by financing activities	3,420,000	3,392,761
Effect of exchange rate fluctuations on cash	(120)	(4,451)
Net change in cash	250,594	29,371
Cash, beginning of the period	79,847	1,994
Cash, end of the period	330,441	31,365
Supplemental disclosure of cash flow information:
Interest paid	165,900	158,367
Income taxes paid	3,668
Supplemental disclosure of non-cash investing and financing information:
Forgiveness of net liabilities owed to former majority shareholder		15,289
Shares issuable related to convertible note payable		1,492,188
Transfer of notes payable to notes payable - related party	1,820,000
Transfer of convertible note payable to notes payable	1,700,000
Debt discount due to derivative liability		620,238
Shares and warrants issued in connection with purchase of trademark	85,583
Conversion of notes payable and accrued interest into common stock	687,037
Warrants and shares issued with note payable	195,061
Net assets contributed from Slinger Bag Limited		$ (967,680)

Organization and Basis of Prese

Organization and Basis of Presentation	9 Months Ended
	Jan. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Basis of Presentation	NOTE 1: ORGANIZATION AND BASIS OF PRESENTATION Organization Lazex Inc. (“Lazex”) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (“Slinger Bag Americas”) which was 100% owned by Slinger Bag Ltd. (“SBL”), an Israeli company. In connection with the Stock Purchase Agreement, Slinger Bag Americas acquired 20,000,000 shares of common stock of Lazex for $332,239. On September 16, 2019, SBL transferred its ownership of Slinger Bag Americas to Lazex in exchange for the 20,000,000 shares of Lazex acquired on August 23, 2019. As a result of these transactions, Lazex owned 100% of Slinger Bag Americas and the sole shareholder of SBL now owned 20,000,000 shares of common stock (approximately 82%) of Lazex. Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc. On October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (“Slinger Bag Canada”) a Canadian company incorporated on November 3, 2017. There are no assets or liabilities or historical operational activity of Slinger Bag Canada at the time of acquisition. On February 10, 2020, Slinger Bag Americas became the 100% owner of SBL, along with SBL’s wholly owned subsidiary Slinger Bag International (UK) Limited (“Slinger Bag UK”) formed on April 3, 2019, after Zehava Tepler, the owner of SBL, contributed it to Slinger Bag Americas for no consideration. The operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK and SBL are collectively referred to as the “Company.” The Company operates in the sporting and athletic goods business. The Company is the owner of Slinger Launcher, which is a portable tennis ball launcher. Effective February 25, 2020, the Company increased its number of authorized shares of common stock from 75,000,000 to 300,000,000 and effected a four-to-one forward split of the outstanding shares of common stock. All share and per share information contained in this report have been retroactively adjusted to reflect the impact of the stock split. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). As a result of the transactions described above, the accompanying consolidated financial statements include the combined results of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK and SBL for the year ended April 30, 2020. The contribution of the net assets of SBL is reflected as an equity contribution at historical cost on May 1, 2019, the beginning of the earliest period in which the entities were under common control. Therefore, the comparative information presented in the unaudited condensed consolidated financial statements for the three and nine months ended January 31, 2020, includes the activity of SBL. There was no historical activity in Slinger Bag Americas, Slinger Bag Canada or Slinger Bag UK prior to May 1, 2019. All intercompany accounts and transactions have been eliminated in consolidation.

Going Concern

Going Concern	9 Months Ended
	Jan. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 2: GOING CONCERN The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has an accumulated deficit of $15,417,751 as of January 31, 2021 and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or being able to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they become due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related parties, and/or private placement of common stock.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Jan. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Interim Financial Statements These unaudited condensed consolidated financial statements reflect all adjustments including normal recurring adjustments, which, in the opinion of management, are necessary to present fairly the financial position, results of operations, and cash flows for the periods presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). These unaudited condensed consolidated financial statements and notes included herein should be read in conjunction with the Company’s financial statements and notes thereto for the years ended April 30, 2020 and 2019, respectively, which are included in the Company’s Form 10-K filed with the United States Securities and Exchange Commission on August 24, 2020. The Company assumes that the users of the interim financial information herein have read, or have access to, the audited consolidated financial statements for the preceding period, and that the adequacy of additional disclosure needed for a fair presentation of these may be determined in that context. The results of operations for the nine months ended January 31, 2021 are not necessarily indicative of results for the entire year ending April 30, 2021. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Accordingly, actual results could differ from those estimates. Financial Statement Reclassification Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications. Cash and Cash Equivalents The Company considers all highly liquid temporary cash investments with an original maturity of three months or less when purchased, to be cash equivalents. Accounts Receivable The Company’s accounts receivable are non-interest-bearing trade receivables resulting from the sale of products and payable over terms ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful. Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The Company has no allowance for doubtful accounts as of January 31, 2021 or April 30, 2020. Inventory Inventory is valued at the lower of the cost or net realizable value. The Company’s inventory as of January 31, 2021 consisted $962,771 of finished goods and $1,358,655 of component and replacement parts. The Company’s inventory as of April 30, 2020 consisted of $663,750 of finished goods and $255,894 of component and replacement parts. Intangible asset Intangible asset, represents “Slinger” technology trademark, which the Company purchased on November 10, 2020. The trademark has a definite life, accordingly is amortized over its expected life of 20 years. Concentration of Credit Risk The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash or cash equivalents. Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606. The Company’s contracts with customers contain one performance obligation. The Company recognizes revenue for its performance obligation at a point in time once products are shipped or physically delivered, depending on the third-party shipping terms. The Company’s sales contracts include a fixed price which becomes payable when performance of the obligation is complete. Amounts collected from customers in advance of revenue being recognized are reflected as deferred revenue on the accompanying unaudited condensed consolidated balance sheets. The Company’s standard terms are non-cancelable and do not provide for the right-of-return, other than for defective merchandise covered under the Company’s standard warranty. The Company has not historically experienced any significant returns or warranty issues. Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in the absence of a principal, most advantageous market for the specific asset or liability. GAAP provides for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows: ● Level 1 — Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access. ● Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including: – Quoted prices for similar assets or liabilities in active markets – Quoted prices for identical or similar assets or liabilities in markets that are not active – Inputs other than quoted prices that are observable for the asset or liability – Inputs that are derived principally from or corroborated by observable market data by correlation or other means ● Level 3 — Inputs that are unobservable and reflect the Company’s own assumptions about the assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows). The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable and amounts due to related parties. The carrying amount of these financial instruments approximates fair value due to their short-term maturity. The Company’s derivative liability was calculated using Level 2 assumptions. Income Taxes Income taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts expected to be realized, but no less than quarterly. Long-Lived Assets In accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. Impairment, if any, is based on the excess of the carrying amount over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. There was no impairment of long-lived assets identified during the three or nine months ended January 31, 2021 or 2020. Share-Based Payment The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation-Stock Compensation, or ASC 718. Under the fair value recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period. Warrants The Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in connection with certain note payable agreements. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants granted in connection with ongoing arrangements are more fully described in Note 5: Note Payable – Related Party, Note 6: Note Payable and Note 9: Stockholders’ Deficit. The warrants granted during the nine months ended January 31, 2021 and 2020 were valued using the Black-Scholes pricing method on the date of grant using the following assumptions below. 2021 2020 Expected life in years 5-10 years NA Stock price volatility 148.3% - 151.9 % NA Risk free interest rate 0.68% - 0.85 % NA Expected dividends 0 % NA Foreign Exchange A portion of SBL’s operations are conducted in Israel and its functional currency is the Israeli Shekel. In addition, the operations of Slinger Bag Canada are conducted in its functional currency of Canadian Dollars. The accounts of SBL and Slinger Bag Canada have been translated into U.S. dollars (“USD”). Assets and liabilities are translated into USD at the applicable exchange rates at period-end. Stockholders’ equity is translated using historical exchange rates. Revenue and expenses are translated at the average exchange rates for the period. Any translation adjustments are included as foreign currency translation adjustments in accumulated other comprehensive income in the Company’s stockholders’ equity. Basic and Diluted Earnings Per Share Basic earnings per share are calculated by dividing income available to stockholders by the weighted-average number of common shares outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common share equivalents outstanding during the period. The Company had 6,921,299 and 8,137,859 common shares issuable as of January 31, 2021 and 2020, respectively, (see Note 6) which were not included in the calculation of diluted earnings per share as the effect is antidilutive. The Company also had outstanding warrants exercisable into 16,200,000 shares of common stock as of January 31, 2021 which were excluded from the calculation of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each of the periods presented. Recent Accounting Pronouncements In December 2019, the FASB issued Accounting Standards Update (“ASU”), 2019-12, Simplifying the Accounting for Income Taxes Income Taxes Other accounting pronouncements have been issued but deemed by management to be outside the scope of relevance to the Company.

Intangible Asset

Intangible Asset	9 Months Ended
	Jan. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Asset	NOTE 4: INTANGIBLE ASSET On November 10, 2020, the Company entered into a Trademark Assignment Agreement to acquire the “Slinger” trademark for $30,000 in cash, 35,000 shares of the Company’s common stock, and warrants to purchase 50,000 shares of the Company’s common stock at an exercise price of $0.50 per share. The warrants are exercisable immediately and have a contractual life of 10 years. The common stock was valued at the closing stock exchange price on November 10, 2020 and the warrants were valued using the Black-Scholes model, for a fair value of $35,351 and $50,232, respectively. The purchase cost of the trademark was determined to be $115,583 and depreciation expense since the date of acquisition is $1,299.

Note Payable - Related Party

Note Payable - Related Party	9 Months Ended
	Jan. 31, 2021
Debt Disclosure [Abstract]
Note Payable - Related Party	NOTE 5: NOTE PAYABLE – RELATED PARTY On October 3, 2019, the Company entered into a loan agreement with a related party entity controlled by the former shareholder of Slinger Bag Canada for borrowings of $500,000 bearing interest at 12% per annum. All principal and accrued interest were due on demand under the original agreement. On December 13, 2019, the Company entered into an Amended and Restated Loan Agreement making all principal and accrued interest and was due on July 15, 2020, later extended to September 1, 2021. On December 3, 2019, the Company entered into a loan agreement with the same related party for borrowings of $500,000 bearing interest at 12% per annum. All principal and accrued interest were due on demand under the original agreement. On December 13, 2019, the Company entered into an Amended and Restated Loan Agreement increasing the interest rate earned from 12% to 24% per annum and making all principal and accrued interest due on July 15, 2020 and was then extended to September 1, 2021. On December 11, 2019, the Company entered into a loan agreement with the same related party for borrowings of $700,000 bearing interest at 24% per annum. All principal and accrued interest were due on July 15, 2020 and was then extended to September 1, 2021. On January 6, 2019, the Company entered into a loan agreement with the same related party for borrowings of $200,000 bearing interest at 24% per annum. All principal and accrued interest were due on January 8, 2021 and was then extended to September 1, 2021. On March 1, 2020, the Company entered into a loan agreement with the same related party for borrowings of $200,000 bearing interest at 24% per annum. All outstanding borrowings and accrued interest under all agreements were due on January 8, 2021 and was then extended to September 1, 2021. On May 12, 2020, the Company borrowed an additional $1,000,000 from the same related party, and on July 3, 2020 the Company borrowed an additional $500,000 from the same related party. The borrowings bear interest at a rate of 24% per annum and were due on January 8, 2021 and was then extended to September 1, 2021. On July 8, 2020, the Company entered into a Purchase Order Financing Agreement (“PO Financing Agreement”) whereby $1,900,000 of the total $3,600,000 in outstanding debt due to the related party as of the date of the agreement has been labeled as inventory financing (“PO Financing Amount”). The PO Financing Amount, along with any accrued interest, is due in full no later than nine months from the effective date of the PO Financing Agreement, or January 8, 2021 and was then extended to September 1, 2021. The outstanding balance of the PO Financing Amount bears interest at a rate of 2% per month. The Company has agreed to repay the PO Financing Amount together with any accrued, but unpaid, interest thereon out proceeds from the sale of its products, licensing activities, revenue to be generated from operations and/or amounts received by the Company from investors, lenders, financiers, financing sources or other persons before making payments of any other nature (including dividends and distributions) except for payments required to finance the Company’s operations. On August 10, 2020, the Company borrowed an additional $250,000 from its existing related party lender subject to the PO Financing Agreement. On September 7, 2020, the outstanding debt from the existing related party lender was amended to reduce the interest rate to 9.5% per annum on all outstanding loans. As consideration for agreeing to reduce the interest rate, the Company issued the related party warrants to purchase 2,500,000 shares of the Company’s common stock at an exercise of $0.001 per share. The warrants vest immediately and have a contractual life of 10 years. The amendment of the outstanding debt was treated as an extinguishment of the debt, and therefore the value of the warrants issued to the lender amounting to $1,999,487 were expensed as loss on extinguishment during the nine months ended January 31, 2021. On September 8, 2020, the related party lender agreed to extend the due date of all outstanding loans to September 1, 2021. On September 15, 2020, the Company borrowed an additional $250,000 existing related party lender. The borrowings bear interest at 9.5% per annum and are due in full on September 15, 2021. In connection with the loan, the Company issued warrants to the related party lender to purchase 125,000 shares of the Company’s common stock at $0.001 per share. The warrants vest immediately and have a contractual life of 10 years. The note was discounted by $70,130 allocated from the valuation of the warrants issued. The discount recorded on the note is being amortized through the maturity date, which amounted to $8,838 and $17,676 for the three and nine months ended January 31, 2021. As of January 31, 2021, the remaining discount was $52,454. On November 24, 2020, the Company borrowed $300,000 from its related party debt holder. The borrowings bear interest at 9.5% per annum and are due in full on November 24, 2021. In connection with the loan, the Company issued warrants to the related party lender to purchase 125,000 shares of the Company’s common stock at $0.001 per share. The warrants vest immediately and have a contractual life of 10 years. This note was discounted by $124,931 allocated from the valuation of the warrants issued. The discount recorded on the note is being amortized through the maturity date, which amounted to $23,275 for the three and nine months ended January 31, 2021. As of January 31, 2021, the remaining discount was $101,656. On December 3, 2020, Montsaic entered into an Assignment and Conveyance Agreement with 2490585 Ontario Inc., the Company’s existing related party lender. In connection with the agreement, Montsaic sold its full right, title and interest in its outstanding notes payable amounting to $1,820,000 to 2490585 Ontario, Inc., along with the 1,216,560 shares of common stock previously issued to Montsaic in connection with the debt agreement and the rights to receive the remaining 6,921,299 shares issuable. Subsequent to this point in time, the outstanding debt of $1,820,000 and all accrued interest is payable to 2490585 Ontario, Inc., and future interest will accrue at a rate of 9.5% per annum consistent with the rate being charged on their other outstanding debt. The scheduled maturity date of the debt remains unchanged and is due June 1, 2021. Total outstanding borrowings from this related party as of January 31, 2021 amounted to $6,220,000. The outstanding amount is net of total discounts of $154,110 for a net book value of $6,065,890 as of January 31, 2021. Interest expense to this related party for three and nine months ended January 31, 2021 amounted to $137,480 and $454,029, respectively. Interest expense to this related party for the three and nine months ended January 31, 2020 amounted to $7,500 and $12,500, respectively. Accrued interest due to this related party as of January 31, 2021 and April 30, 2020 amounted to $592,997 and $138,967, respectively.

Convertible Notes Payable

Convertible Notes Payable	9 Months Ended
	Jan. 31, 2021
Debt Disclosure [Abstract]
Convertible Notes Payable	NOTE 6: CONVERTIBLE NOTES PAYABLE On February 11, 2020, the Company entered into a convertible note payable agreement for borrowings of $125,000 bearing interest at 12% per annum. All outstanding borrowings and accrued interest are due on February 11, 2021. The outstanding principal and accrued interest are convertible into shares of the Company’s common stock at any time at the option of the debtholder at a conversion price equal to 70% of the lowest closing price of the common stock as defined in the agreement. On September 4, 2020, the holder of the outstanding convertible note payable elected to convert the outstanding principal and accrued interest balance into 300,000 shares of the Company’s common stock. The Company evaluated the conversion option under the guidance in ASC 815-10, Derivatives and Hedging, and determined it to have characteristics of a derivative liability. Under this guidance, this derivative liability is marked-to-market at each reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivatives. The value of the conversion option amounted to $53,571 as of the issuance date on February 11, 2020, which was initially recorded as a discount to the outstanding note balance and a derivative liability. The discount was being amortized over the term of the agreement. On September 4, 2020, to induce the convertible debt holder to promptly convert the outstanding balance into shares of the Company’s common stock, the Company offered the debt holder a one-time reduction in the conversion price. The debt holder subsequently agreed to convert the outstanding convertible note payable balance of $125,000 and accrued interest of $8,466 into 300,000 shares of the Company’s common stock. Under the guidance in ASC 470-20-40-16, the Company recognized an expense at the conversion date equal to the fair value of the stock transferred after the change in terms, less the fair value of securities issuable under the original conversion terms. The excess in value amounted to $51,412, and was reflected as induced conversion loss in the accompanying unaudited condensed consolidated statement of operations in the nine months ended January 31, 2021. At the time of the conversion, the remaining debt discount was fully amortized and the derivative liability amount of $53,571 was reclassified as additional paid-in capital as part of stockholders’ equity. Amortization of debt discounts during the nine months ended January 31, 2021 amounted to $42,872, and is recorded as amortization of debt discount in the accompanying unaudited condensed consolidated statements of operations.

Note Payable

Note Payable	9 Months Ended
	Jan. 31, 2021
Debt Disclosure [Abstract]
Note Payable	NOTE 7: NOTE PAYABLE On June 1, 2019, the Company entered into a note payable agreement with Montsaic Investments (“Montsaic”) which provided for borrowings of $1,700,000 bearing interest at a rate of 12.6% per annum. All outstanding amounts were due on the maturity date 360 days after the loan issue date. The Company may repay up to 50% of the outstanding balance on the loan prior to the maturity date at their discretion. The outstanding principal and accrued interest were convertible into shares of the Company’s common stock at any time at the option of the debtholder at a conversion price equal to 75% of the lowest closing price of the common stock as defined in the agreement. Effective June 1, 2020, the Company and Montsaic entered into an amendment to the note payable agreement to eliminate the conversion right contained in the original agreement and extend the maturity date to June 1, 2021. The note payable agreement, as amended on September 11, 2019, also provides Montsaic with a warrant giving them the right to acquire 33% of the outstanding shares of SBL on a fully-diluted basis for no consideration up through the maturity date. On September 16, 2019, Montsaic and Slinger Bag Inc. entered into a warrant assignment and conveyance agreement which transferred the right to acquire 33% of the outstanding common stock shares of SBL to Slinger Bag Inc., resulting in a total of 8,137,859 shares of common stock issuable to Montsaic. The allocated value of the warrant amounted to $1,492,188, which has been reflected as a discount to the outstanding note balance. On May 6, 2020, the Company issued 1,216,560 shares of common stock as partial satisfaction of the shares issuable. As of January 31, 2021, the Company has 6,921,299 shares of common stock that are issuable. The Company evaluated the conversion option under the guidance in ASC 815-10, Derivatives and Hedging, and determined it to have characteristics of a derivative liability. Under this guidance, this derivative liability is marked-to-market at each reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivatives. The value of the conversion option amounted to $566,667 as of the issuance date on September 11, 2019, which has been recorded as a discount to the outstanding note balance, less $358,855 representing the amount of the conversion option exceeding the face value of the note payable which was recorded immediately as interest expense, and a derivative liability. Effective June 1, 2020, the Company and Montsaic entered into an amendment to the note payable agreement to eliminate the conversion right contained in the original agreement. As a result, the value of the derivative liability was $0 as of January 31, 2021 and the Company has recorded a gain on the change in value of derivative of $566,667 during the nine months ended January 31, 2021. On June 30, 2020, the Company entered into a loan agreement with Montsaic to borrow an additional $120,000. This loan bears interest at an annual rate of 12.6% and is required to be repaid in full, together with all accrued, but unpaid, interest by June 30, 2021. On December 3, 2020, Montsaic sold its full right, title and interest in its outstanding notes payable amounting to $1,820,000 to 2490585 Ontario, Inc., the Company’s existing related party lender, along with the 1,216,560 shares of common stock previously issued in connection with the debt agreement and the rights to receive the remaining 6,921,299 shares issuable. On March 16, 2020, the Company entered into a promissory note payable whereby the Company borrowed $500,000 bearing interest at 12% per annum. Interest on the note is payable monthly and outstanding principal on the note is due in full on March 16, 2022. In connection with the promissory note payable on March 16, 2020, the Company issued warrants to purchase 500,000 shares of the Company’s common stock at an exercise price equal to a 40% discount of the market price of the Company’s stock, as defined in the agreement. The warrants expire on March 16, 2022 and are fully vested upon issuance. The note was discounted by $112,990 allocated from the valuation of the warrants issued. The discount recorded on the note is being amortized through the maturity date, which amounted to $7,415 and $35,895, respectively, for the three and nine months ended January 31, 2021. On December 15, 2020, the debt holder agreed to convert the outstanding note payable of $500,000 into 500,000 shares of the Company’s common stock as full settlement of the promissory note payable. Accrued interest on the note was paid in cash. As a result of this settlement, the Company recognized the unamortized debt discount of $70,483 as a loss on loan extinguishment in the statement of operations in the three- and nine-month period ended January 31, 2021. On December 24, 2020, the Company entered into a promissory note with a third party to borrow $1,000,000. The promissory note bears interest at 2.25% and is due February 8, 2021. On February 2, 2021, the Company extended its promissory note to April 30, 2021. As of January 31, 2021, the outstanding amount of $1,000,000 is due and payable on April 30, 2021.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Jan. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 8: RELATED PARTY TRANSACTIONS In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attain adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by officers, directors, or shareholders. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are considered temporary in nature and have not been formalized by a promissory note. Amounts due to related parties were $1,085,434 and $377,106 as of January 31, 2021 and April 30, 2020, respectively, which represented unpaid salaries and reimbursable expenses due to officers of the Company. The Company has outstanding notes payable of $6,220,000 and $2,100,000 and accrued interest of $592,997 and $138,967 due to a related party as of January 31, 2021 and April 30, 2020, respectively (see Note 5).

Stockholders' Deficit

Stockholders' Deficit	9 Months Ended
	Jan. 31, 2021
Stockholders' Equity Note [Abstract]
Stockholders' Deficit	NOTE 9: STOCKHOLDERS’ DEFICIT Common Stock The Company has 300,000,000 shares of common stock authorized with a par value of $0.001 per share. As of January 31, 2021, the Company had 27,346,746 shares of common stock issued and outstanding. On May 6, 2020, the Company issued 1,216,560 shares of its common stock to Montsaic as partial satisfaction of the shares issuable under this note payable agreement. On May 15, 2020, the Company issued 243,800 shares of its common stock to a vendor as compensation for business advisory services performed which resulted in $65,826 of operating expenses during the nine-month period ended January 31, 2021. On September 4, 2020, the Company issued 300,000 shares of its common stock for the conversion of debt (see Note 6). The fair value of the common stock was $238,449. On October 8, 2020, the Company issued 100,000 shares of its common stock to a vendor as compensation for business advisory services performed which resulted in $114,000 of operating expenses during the nine months ended January 31, 2021. On November 24, 2020 and on January 11, 2021, the Company issued 46,087 and 100,000 shares of its common stock to two vendors as compensation for marketing and other advisory services, which resulted in an expense of $103,250 during the nine-month period ended January 31, 2021. The Company also issued 55,945 shares of its common stock on November 24, 2020 to a third-party vendor as full settlement of payables of $30,000 related to consulting services, which resulted in a $25,278 loss on extinguishment of debt. The total fair value of the common stock was $198,386, of which $39,750 has been recognized in prepaids and other assets and will be recognized over the period that the related services are rendered. On November 10, 2020, the Company issued 35,000 common stock of the Company as partial payment for the purchase of Slinger trademark. The common stock had a fair value of $35,351 on the date of issuance which has been capitalized as an intangible asset on the balance sheet. On December 15, 2020, the Company issued 500,000 common stock of the Company as full payment of its $500,000 notes payable to a third party (see Note 7). The fair value of the common stock was $500,000. Common Stock Issuable As discussed in Note 7, on September 16, 2019, the Company entered into a warrant assignment and conveyance agreement with Montsaic, pursuant to which the Company allows Montsaic to acquire 33% of the outstanding common stock shares of the Company on a fully-diluted basis for no consideration. As of January 31, 2021, there are 6,921,299 shares of common stock that are issuable under this agreement. Warrants Issued for Compensation On April 30, 2020, the Company granted an aggregate total of 12,500,000 warrants to key employees and officers of the Company as compensation. The warrants have an exercise price of $0.001 per share, a contractual life of 10 years from the date of issuance, and are vested immediately upon grant. On October 28, 2020, the Company granted 400,000 warrants to a services provider for advertising services over the next year. The warrants have an exercise price of $0.75 per share, a contractual life of 10 years from the date of issuance, and vest quarterly over a year from the grant date. As of January 31, 2021, none of the award has vested or is exercisable. On October 29, 2020, the Company granted a stock-based compensation award to three members of its advisory board, whereby they receive an aggregate number of warrants equal to $90,000 divided by the average closing price of the Company’s stock for the previous five days prior to the most recently completed fiscal quarter. The award vests quarterly over a year from the grant date. The warrants have exercise price of $0.001 per share and a contractual life of 10 years from the date of issuance. The Company recorded a total stock-based compensation expense of $130,275 and $134,294 for the three and nine months ended January 31, 2021. The Company expects to record an additional $382,559 of stock-based compensation expense associated with these warrants through October 2021.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Jan. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 10: COMMITMENTS AND CONTINGENCIES Leases The Company leases its office space under short-term leases with terms under a year. Total rent expense for the three months ended January 31, 2021 and 2020 amounted to $2,100 and $4,200, respectively. Total rent expense for the nine months ended January 31, 2021 and 2020 amounted to $8,400 and $4,200, respectively. Contingencies From time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company is not presently a party to any legal proceedings that it currently believes would individually or taken together have a material adverse effect on the Company’s business or financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Jan. 31, 2021
Accounting Policies [Abstract]
Interim Financial Statements	Interim Financial Statements These unaudited condensed consolidated financial statements reflect all adjustments including normal recurring adjustments, which, in the opinion of management, are necessary to present fairly the financial position, results of operations, and cash flows for the periods presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). These unaudited condensed consolidated financial statements and notes included herein should be read in conjunction with the Company’s financial statements and notes thereto for the years ended April 30, 2020 and 2019, respectively, which are included in the Company’s Form 10-K filed with the United States Securities and Exchange Commission on August 24, 2020. The Company assumes that the users of the interim financial information herein have read, or have access to, the audited consolidated financial statements for the preceding period, and that the adequacy of additional disclosure needed for a fair presentation of these may be determined in that context. The results of operations for the nine months ended January 31, 2021 are not necessarily indicative of results for the entire year ending April 30, 2021.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Accordingly, actual results could differ from those estimates.
Financial Statement Reclassification	Financial Statement Reclassification Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid temporary cash investments with an original maturity of three months or less when purchased, to be cash equivalents.
Accounts Receivable	Accounts Receivable The Company’s accounts receivable are non-interest-bearing trade receivables resulting from the sale of products and payable over terms ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful. Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The Company has no allowance for doubtful accounts as of January 31, 2021 or April 30, 2020.
Inventory	Inventory Inventory is valued at the lower of the cost or net realizable value. The Company’s inventory as of January 31, 2021 consisted $962,771 of finished goods and $1,358,655 of component and replacement parts. The Company’s inventory as of April 30, 2020 consisted of $663,750 of finished goods and $255,894 of component and replacement parts.
Intangible Asset	Intangible asset Intangible asset, represents “Slinger” technology trademark, which the Company purchased on November 10, 2020. The trademark has a definite life, accordingly is amortized over its expected life of 20 years.
Concentration of Credit Risk	Concentration of Credit Risk The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash or cash equivalents.
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606. The Company’s contracts with customers contain one performance obligation. The Company recognizes revenue for its performance obligation at a point in time once products are shipped or physically delivered, depending on the third-party shipping terms. The Company’s sales contracts include a fixed price which becomes payable when performance of the obligation is complete. Amounts collected from customers in advance of revenue being recognized are reflected as deferred revenue on the accompanying unaudited condensed consolidated balance sheets. The Company’s standard terms are non-cancelable and do not provide for the right-of-return, other than for defective merchandise covered under the Company’s standard warranty. The Company has not historically experienced any significant returns or warranty issues.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in the absence of a principal, most advantageous market for the specific asset or liability. GAAP provides for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows: ● Level 1 — Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access. ● Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including: – Quoted prices for similar assets or liabilities in active markets – Quoted prices for identical or similar assets or liabilities in markets that are not active – Inputs other than quoted prices that are observable for the asset or liability – Inputs that are derived principally from or corroborated by observable market data by correlation or other means ● Level 3 — Inputs that are unobservable and reflect the Company’s own assumptions about the assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows). The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable and amounts due to related parties. The carrying amount of these financial instruments approximates fair value due to their short-term maturity. The Company’s derivative liability was calculated using Level 2 assumptions.
Income Taxes	Income Taxes Income taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts expected to be realized, but no less than quarterly.
Long-Lived Assets	Long-Lived Assets In accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. Impairment, if any, is based on the excess of the carrying amount over the fair value, based on market value when available, or discounted expected cash flows, of those assets and is recorded in the period in which the determination is made. There was no impairment of long-lived assets identified during the three or nine months ended January 31, 2021 or 2020.
Share-Based Payment	Share-Based Payment The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation-Stock Compensation, or ASC 718. Under the fair value recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.
Warrants	Warrants The Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in connection with certain note payable agreements. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants granted in connection with ongoing arrangements are more fully described in Note 5: Note Payable – Related Party, Note 6: Note Payable and Note 9: Stockholders’ Deficit. The warrants granted during the nine months ended January 31, 2021 and 2020 were valued using the Black-Scholes pricing method on the date of grant using the following assumptions below. 2021 2020 Expected life in years 5-10 years NA Stock price volatility 148.3% - 151.9 % NA Risk free interest rate 0.68% - 0.85 % NA Expected dividends 0 % NA
Foreign Exchange	Foreign Exchange A portion of SBL’s operations are conducted in Israel and its functional currency is the Israeli Shekel. In addition, the operations of Slinger Bag Canada are conducted in its functional currency of Canadian Dollars. The accounts of SBL and Slinger Bag Canada have been translated into U.S. dollars (“USD”). Assets and liabilities are translated into USD at the applicable exchange rates at period-end. Stockholders’ equity is translated using historical exchange rates. Revenue and expenses are translated at the average exchange rates for the period. Any translation adjustments are included as foreign currency translation adjustments in accumulated other comprehensive income in the Company’s stockholders’ equity.
Basic and Diluted Earnings Per Share	Basic and Diluted Earnings Per Share Basic earnings per share are calculated by dividing income available to stockholders by the weighted-average number of common shares outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common share equivalents outstanding during the period. The Company had 6,921,299 and 8,137,859 common shares issuable as of January 31, 2021 and 2020, respectively, (see Note 6) which were not included in the calculation of diluted earnings per share as the effect is antidilutive. The Company also had outstanding warrants exercisable into 16,200,000 shares of common stock as of January 31, 2021 which were excluded from the calculation of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each of the periods presented.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In December 2019, the FASB issued Accounting Standards Update (“ASU”), 2019-12, Simplifying the Accounting for Income Taxes Income Taxes Other accounting pronouncements have been issued but deemed by management to be outside the scope of relevance to the Company.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Jan. 31, 2021
Accounting Policies [Abstract]
Summary of Warrants Granted Valuation using Black-Scholes Pricing Method	The warrants granted during the nine months ended January 31, 2021 and 2020 were valued using the Black-Scholes pricing method on the date of grant using the following assumptions below. 2021 2020 Expected life in years 5-10 years NA Stock price volatility 148.3% - 151.9 % NA Risk free interest rate 0.68% - 0.85 % NA Expected dividends 0 % NA

Organization and Basis of Pre_2

Organization and Basis of Presentation (Details Narrative) - USD ($)	Sep. 16, 2019	Aug. 23, 2019	Jan. 31, 2021	Apr. 30, 2020	Feb. 25, 2020	Feb. 24, 2020	Feb. 10, 2020
Common stock, shares authorized			300,000,000	300,000,000	300,000,000	75,000,000
Stock split, description			four-to-one forward split of the outstanding shares of common stock
Sole Shareholder of SBL [Member]
Ownership percentage	82.00%
Number of shares owned	20,000,000
Slinger Bag Americas Inc [Member]
Ownership percentage	100.00%
Number of shares exchanged	20,000,000
Slinger Bag Ltd [Member]
Ownership percentage							100.00%
Stock Purchase Agreement [Member] | Slinger Bag Americas Inc [Member]
Ownership percentage		100.00%
Number of shares issued for acquisition		20,000,000
Number of shares issued for acquisition, value		$ 332,239

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Jan. 31, 2021	Apr. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ (15,417,751)	$ (10,228,513)

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	9 Months Ended
	Jan. 31, 2021	Jan. 31, 2020	Apr. 30, 2020
Accounts receivable, allowance for doubtful accounts
Inventory finished goods	2,962,771		663,750
Inventory component and replacement parts	$ 13,586,559		$ 255,894
Expected life for trademarks	20 years
Impairment of long-lived assets
Antidilutive securities earnings per share	6,921,299	8,137,859
Warrants [Member]
Antidilutive securities earnings per share	16,200,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Warrants Granted Valuation using Black-Scholes Pricing Method (Details) - Warrant [Member] - Valuation Technique, Option Pricing Model [Member]	9 Months Ended
	Jan. 31, 2021	Jan. 31, 2020
Expected Life in Years [Member]
Measurement input, term		0 years
Expected Life in Years [Member] | Minimum [Member]
Measurement input, term	5 years
Expected Life in Years [Member] | Maximum [Member]
Measurement input, term	10 years
Stock Price Volatility [Member]
Measurement input, rate		0
Stock Price Volatility [Member] | Minimum [Member]
Measurement input, rate	148.3
Stock Price Volatility [Member] | Maximum [Member]
Measurement input, rate	151.9
Risk Free Interest Rate [Member]
Measurement input, rate		0
Risk Free Interest Rate [Member] | Minimum [Member]
Measurement input, rate	0.68
Risk Free Interest Rate [Member] | Maximum [Member]
Measurement input, rate	0.85
Expected Dividends [Member]
Measurement input, rate	0	0

Intangible Asset (Details Narra

Intangible Asset (Details Narrative) - USD ($)	Nov. 10, 2020	Nov. 10, 2020	Jan. 31, 2021	Jan. 31, 2020
Purchase of trademark			$ 30,000
Shares issued in connection with purchase of trademark, shares	35,000
Fair value of warrants			$ 35,351	$ 50,232
Trademark Assignment Agreement [Member]
Purchase of trademark		$ 30,000
Shares issued in connection with purchase of trademark, shares		35,000
Warrants to purchase common stock	50,000	50,000
Warrants exercise price	$ 0.50	$ 0.50
Warrants term	10 years	10 years
Purchase price for trademark	$ 115,583	$ 115,583
Depreciation expense	$ 1,299	$ 1,299

Note Payable - Related Party (D

Note Payable - Related Party (Details Narrative) - USD ($)	Dec. 03, 2020	Nov. 24, 2020	Sep. 15, 2020	Sep. 07, 2020	May 12, 2020	Mar. 02, 2020	Dec. 13, 2019	Dec. 11, 2019	Jan. 06, 2019	Jan. 31, 2021	Jan. 31, 2020	Jan. 31, 2021	Jan. 31, 2020	Aug. 10, 2020	Jul. 08, 2020	Jul. 03, 2020	Apr. 30, 2020	Dec. 03, 2019	Oct. 03, 2019
Borrowings										$ 6,065,890		$ 6,065,890					$ 2,100,000
Outstanding amount is net of total discounts										154,110		154,110
Outstanding debt										$ 6,065,890		$ 6,065,890
Shares issuable	6,921,299									6,921,299		6,921,299					6,921,299
Interest expenses related party debt										$ 137,480	$ 7,500	$ 454,029	$ 12,500
Accrued interest - related parties										592,997		592,997					$ 138,967
Ontario Inc. [Member]
Borrowings	$ 1,820,000
Interest rate	9.50%
Number of common stock previously issued	1,216,560
Shares issuable	6,921,299
Former Shareholder [Member]
Borrowings										3,600,000		3,600,000
Lender [Member]
Borrowings			$ 250,000											$ 250,000
Interest rate			95.00%
Debt instrument maturity date			Sep. 15, 2021	Sep. 30, 2021
Number of warrants issued to purchase common shares			125,000	2,500,000
Warrants, exercise price			$ 0.001	$ 0.001
Warrants, term			10 years	10 years
Extinguishment of the debt										1,999,487		1,999,487
Valuation of the warrants issued discounted			$ 70,130							8,838		17,676
Remaining warrant issued discount										52,454		52,454
Lender [Member] | Interest Rate Reduction [Member]
Interest rate				95.00%
Related Party Debt Holder [Member]
Borrowings		$ 300,000
Interest rate		9.50%
Debt instrument maturity date		Nov. 24, 2021
Number of warrants issued to purchase common shares		125,000
Warrants, exercise price		$ 0.001
Warrants, term		10 years
Valuation of the warrants issued discounted										23,275		23,275
Remaining warrant issued discount										$ 101,656		$ 101,656
Debt discount		$ 124,931
Loan Agreement [Member] | Former Shareholder [Member]
Borrowings					$ 1,000,000	$ 200,000		$ 700,000	$ 200,000							$ 500,000		$ 500,000	$ 500,000
Interest rate					24.00%	24.00%		24.00%	24.00%							24.00%		12.00%	12.00%
Debt instrument maturity date					Jan. 8, 2021	Jan. 8, 2021		Jul. 15, 2020	Jan. 8, 2021
Debt instrument extended maturity date					Sep. 1, 2021	Sep. 1, 2021		Sep. 1, 2021	Sep. 1, 2021
Amended and Restated Loan Agreement [Member]
Debt instrument maturity date							Jul. 15, 2020
Debt instrument extended maturity date							Sep. 1, 2021
Amended and Restated Loan Agreement [Member] | Minimum [Member]
Interest rate							12.00%
Amended and Restated Loan Agreement [Member] | Maximum [Member]
Interest rate							24.00%
Purchase Order Financing Agreement [Member]
Borrowings															$ 1,900,000
Interest rate															2.00%

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative) - USD ($)	Dec. 03, 2020	Sep. 04, 2020	Sep. 04, 2020	May 06, 2020	Feb. 11, 2020	Jan. 31, 2021	Apr. 30, 2020
Company common stock	1,216,560		300,000	1,216,560
Outstanding convertible note payable		$ 125,000	$ 125,000
Accrued interest		$ 8,466	$ 8,466			$ 19,500	$ 17,500
Excess in value amounted to conversion loss						51,412
Derivative liability						53,571
Amortization of debt discount						$ 42,872
Convertible Note Payable Agreement [Member]
Convertible note payable					$ 125,000
Debt instrument interest rate					12.00%
Debt instrument due date					Feb. 11, 2021
Options for debtholders conversion price percentage					70.00%
Amount of conversion option					$ 53,571
Convertible Note Payable Agreement [Member] | Conversion of Outstanding Debt and Accrued Interest [Member]
Debt conversion converted instrument, shares		300,000

Note Payable (Details Narrative

Note Payable (Details Narrative) - USD ($)	Feb. 02, 2021	Dec. 24, 2020	Dec. 15, 2020	Dec. 03, 2020	Sep. 04, 2020	Jun. 30, 2020	May 06, 2020	Mar. 16, 2020	Sep. 11, 2019	Jun. 02, 2019	Jan. 31, 2021	Jan. 31, 2020	Jan. 31, 2021	Jan. 31, 2020	Apr. 30, 2020	Sep. 16, 2019
Shares issuable				6,921,299							6,921,299		6,921,299		6,921,299
Number of common shares issued during period, shares				1,216,560	300,000		1,216,560
Debt conversion converted instrument, value													$ 687,037
Derivative liability											$ 0		0
Gain on derivative liability													566,667
Amortization of debt discount											39,175	$ 602,963	325,426	$ 924,933
Unamortized debt discount											70,483		70,483
Debt principal amount outstanding											6,065,890		6,065,890
Promissory Note Payable [Member]
Note payable								$ 500,000
Debt instrument interest rate								12.00%
Options for debtholders conversion price percentage								40.00%
Debt instrument maturity date								Mar. 16, 2022
Debt conversion converted instrument, value			$ 500,000
Amortization of debt discount											7,415		35,895
Number of warrants issued to purchase common shares								500,000
Valuation of warrants issued								$ 112,990
Debt instrument converted shares			500,000
Debt principal amount outstanding											1,000,000		1,000,000
Promissory Note [Member]
Debt instrument interest rate		2.25%
Debt instrument maturity date		Feb. 8, 2021
Debt principal amount outstanding		$ 1,000,000
Promissory Note [Member] | Subsequent Event [Member]
Debt instrument maturity date	Apr. 30, 2021
Warrant [Member]
Value of warrant											$ 1,492,188		$ 1,492,188
Montsaic Investments [Member]
Shares issuable											8,137,859		8,137,859
Ontario Inc. [Member]
Debt instrument interest rate				9.50%
Shares issuable				6,921,299
Outstanding notes payable				$ 1,820,000
Note Payable Agreement [Member]
Debt conversion converted instrument, value									$ 566,667
Debt issuance date									Sep. 11, 2019
Amount of conversion option									$ 358,855
Note Payable Agreement [Member] | Montsaic Investments [Member]
Note payable										$ 1,700,000
Debt instrument interest rate										12.60%
Debt instrument maturity date, description										All outstanding amounts were due on the maturity date 360 days after the loan issue date.
Maximum percentage of payment on outstanding debt										50.00%
Debt instrument maturity date										Jun. 1, 2021
Ownership percentage									33.00%
Number of common shares issued during period, shares							1,216,560
Note Payable Agreement [Member] | Montsaic Investments [Member] | Debtholder [Member]
Options for debtholders conversion price percentage										75.00%
Warrant Assignment and Conveyance Agreement [Member] | Montsaic Investments [Member]
Ownership percentage																33.00%
Shares issuable											6,921,299		6,921,299
Loan Agreement [Member] | Montsaic Investments [Member]
Note payable						$ 120,000
Debt instrument interest rate						12.60%
Debt instrument maturity date						Jun. 30, 2021

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	Jan. 31, 2021	Apr. 30, 2020
Due to related parties	$ 1,085,434	$ 377,106
Accrued interest - related parties	592,997	138,967
Related Party [Member]
Outstanding notes payable	$ 6,220,000	$ 2,100,000

Stockholders' Deficit (Details

Stockholders' Deficit (Details Narrative) - USD ($)	Jan. 11, 2021	Dec. 15, 2020	Dec. 03, 2020	Nov. 24, 2020	Nov. 10, 2020	Oct. 29, 2020	Oct. 28, 2020	Oct. 08, 2020	Sep. 04, 2020	Sep. 04, 2020	May 15, 2020	May 06, 2020	Apr. 30, 2020	Jan. 31, 2021	Oct. 31, 2020	Jul. 31, 2020	Jan. 31, 2021	Feb. 25, 2020	Feb. 24, 2020	Sep. 16, 2019	Sep. 11, 2019
Common stock, shares authorized													300,000,000	300,000,000			300,000,000	300,000,000	75,000,000
Common stock, par value													$ 0.001	$ 0.001			$ 0.001
Common stock, shares issued													24,749,354	27,346,746			27,346,746
Common stock, shares outstanding													24,749,354	27,346,746			27,346,746
Number of common shares issued during period, shares			1,216,560							300,000		1,216,560
Shares issued for services															$ 114,000	$ 65,826
Shares issued for conversion of convertible debt, shares									300,000
Shares issued for conversion of convertible debt									$ 238,449						$ 238,449
Shares issued in connection with purchase of trademark, shares					35,000
Shares issued in connection with purchase of trademark					$ 35,351									$ 35,351
Shares issuable			6,921,299										6,921,299	6,921,299			6,921,299
Share based compensation expenses														$ 130,275			$ 134,294
October 2021 [Member]
Share based compensation expenses																	382,559
Third Party [Member]
Fair value of common stock		$ 500,000
Shares issued for conversion of convertible debt, shares		500,000
Shares issued for conversion of convertible debt		$ 500,000
Vendor [Member]
Shares issued for services, shares								100,000			243,800
Vendor [Member] | Operating Expense [Member]
Shares issued for services																	65,826
Vendor [Member] | Operating Expense [Member]
Shares issued for services																	114,000
Two Vendor [Member]
Shares issued for services, shares	100,000			46,087
Shares issued for services																	103,250
Third Party Vendor [Member]
Number of common shares issued during period, shares				55,945
Shares issued for services				$ 30,000													198,386
Capitalized service cost																	$ 39,750
Extinguishment of debt				$ 25,278
Key Employees and Officers [Member] | As Compensation [Member]
Warrant issued for employees and officers compensation													12,500,000
Warrants, exercise price													$ 0.001
Warrants, term													10 years
Service Provider [Member]
Warrants, exercise price							$ 0.75
Warrants, term							10 years
Service Provider [Member] | Warrant [Member]
Number of warrants granted							400,000
Three Members [Member] | As Compensation [Member]
Warrants, exercise price						$ 0.001
Warrants, term						10 years
Number of warrants granted						90,000
Montsaic Investments [Member]
Shares issuable														8,137,859			8,137,859
Montsaic Investments [Member] | Note Payable Agreement [Member]
Number of common shares issued during period, shares												1,216,560
Equity ownership, percentage																					33.00%
Montsaic Investments [Member] | Warrant Assignment and Conveyance Agreement [Member]
Equity ownership, percentage																				33.00%
Shares issuable														6,921,299			6,921,299

Commitments And Contingencies (

Commitments And Contingencies (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Jan. 31, 2021	Jan. 31, 2020	Jan. 31, 2021	Jan. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$ 2,100	$ 4,200	$ 8,400	$ 4,200